This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: David A Borthwick: Innovator in Pharmaceutical Chemistry
Introduction
David A Borthwick is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
David A Borthwick holds a patent for guanine derivatives. The present invention provides a compound of formula (I) and salts and solvates thereof. It describes processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of viral diseases, especially those caused by the Herpetoviridae. This patent highlights his innovative approach to addressing viral infections.
Career Highlights
David A Borthwick is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His work there has focused on developing new therapeutic agents that can combat viral diseases. His expertise in this area has positioned him as a valuable asset to his team and the broader scientific community.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Barrie E Kirk and Derek Norman Evans. These collaborations have fostered a productive environment for innovation and research in pharmaceutical development.
Conclusion
David A Borthwick's contributions to the field of pharmaceutical chemistry, particularly through his patent on guanine derivatives, demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the treatment of viral diseases.